FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620504089> ?p ?o ?g. }

• W2620504089 endingPage "786" @default.
• W2620504089 startingPage "781" @default.
• W2620504089 abstract "A nucleosidic medicine, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine [3'-ethynylcytidine (ECyd)], is a potent inhibitor of RNA polymerase I and shows anticancer activity to various human solid tumors in vitro and in vivo. ECyd is phosphorylated to 3'-ethyntlcytidine 5'-monophosphate by uridine/cytidine kinase 2 (UCK2) and subsequently further to diphosphate and triphosphate (3'-ethyntlcytidine 5'-diphosphate, 3'-ethyntlcytidine 5'-triphosphate). 3'-Ethyntlcytidine 5'-triphosphate is an active metabolite that can inhibit RNA polymerase I competitively, causing cancer cell death. Here, to identify the UCK2 mutation for detecting responder or nonresponder to ECyd, we investigated the relationship between point mutation of the UCK2 gene and response to ECyd in various human solid tumors. We identified several functional point mutations including the splice-site mutation of the UCK2 gene IVS5+5 G>A. In addition, we found that the IVS5+5 G>A variant generates an aberrant mRNA transcript, namely, truncated mRNA was produced and normal mRNA levels were markedly decreased in the ECyd-resistant cancer cell line HT1080. We concluded that these findings strongly suggest that the IVS5+5 G>A variant would affect the expression level of the UCK2 transcript, resulting in decreased sensitivity to ECyd." @default.
• W2620504089 created "2017-06-05" @default.
• W2620504089 creator A5008946720 @default.
• W2620504089 creator A5019489630 @default.
• W2620504089 creator A5029970515 @default.
• W2620504089 creator A5044763687 @default.
• W2620504089 creator A5053501652 @default.
• W2620504089 creator A5062680884 @default.
• W2620504089 creator A5068756381 @default.
• W2620504089 creator A5075771709 @default.
• W2620504089 date "2017-08-01" @default.
• W2620504089 modified "2023-10-14" @default.
• W2620504089 title "Role of the uridine/cytidine kinase 2 mutation in cellular sensitiveness toward 3′-ethynylcytidine treatment of human cancer cells" @default.
• W2620504089 cites W1881080407 @default.
• W2620504089 cites W1966127906 @default.
• W2620504089 cites W2004616206 @default.
• W2620504089 cites W2012652749 @default.
• W2620504089 cites W2012766479 @default.
• W2620504089 cites W2015087800 @default.
• W2620504089 cites W2029069595 @default.
• W2620504089 cites W2029929297 @default.
• W2620504089 cites W2040831406 @default.
• W2620504089 cites W2052223432 @default.
• W2620504089 cites W2061560348 @default.
• W2620504089 cites W2066542953 @default.
• W2620504089 cites W2095219457 @default.
• W2620504089 cites W2112085360 @default.
• W2620504089 cites W2142629750 @default.
• W2620504089 cites W2147708332 @default.
• W2620504089 cites W2156985125 @default.
• W2620504089 cites W2513349003 @default.
• W2620504089 cites W2782813509 @default.
• W2620504089 cites W94096219 @default.
• W2620504089 doi "https://doi.org/10.1097/cad.0000000000000519" @default.
• W2620504089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28542039" @default.
• W2620504089 hasPublicationYear "2017" @default.
• W2620504089 type Work @default.
• W2620504089 sameAs 2620504089 @default.
• W2620504089 citedByCount "10" @default.
• W2620504089 countsByYear W26205040892018 @default.
• W2620504089 countsByYear W26205040892019 @default.
• W2620504089 countsByYear W26205040892021 @default.
• W2620504089 countsByYear W26205040892022 @default.
• W2620504089 crossrefType "journal-article" @default.
• W2620504089 hasAuthorship W2620504089A5008946720 @default.
• W2620504089 hasAuthorship W2620504089A5019489630 @default.
• W2620504089 hasAuthorship W2620504089A5029970515 @default.
• W2620504089 hasAuthorship W2620504089A5044763687 @default.
• W2620504089 hasAuthorship W2620504089A5053501652 @default.
• W2620504089 hasAuthorship W2620504089A5062680884 @default.
• W2620504089 hasAuthorship W2620504089A5068756381 @default.
• W2620504089 hasAuthorship W2620504089A5075771709 @default.
• W2620504089 hasConcept C104317684 @default.
• W2620504089 hasConcept C105580179 @default.
• W2620504089 hasConcept C121608353 @default.
• W2620504089 hasConcept C153911025 @default.
• W2620504089 hasConcept C176944494 @default.
• W2620504089 hasConcept C181199279 @default.
• W2620504089 hasConcept C185592680 @default.
• W2620504089 hasConcept C2776023528 @default.
• W2620504089 hasConcept C2777844706 @default.
• W2620504089 hasConcept C2779268695 @default.
• W2620504089 hasConcept C2780258809 @default.
• W2620504089 hasConcept C2781184954 @default.
• W2620504089 hasConcept C2781259782 @default.
• W2620504089 hasConcept C501734568 @default.
• W2620504089 hasConcept C54355233 @default.
• W2620504089 hasConcept C55493867 @default.
• W2620504089 hasConcept C67705224 @default.
• W2620504089 hasConcept C82381507 @default.
• W2620504089 hasConcept C86803240 @default.
• W2620504089 hasConceptScore W2620504089C104317684 @default.
• W2620504089 hasConceptScore W2620504089C105580179 @default.
• W2620504089 hasConceptScore W2620504089C121608353 @default.
• W2620504089 hasConceptScore W2620504089C153911025 @default.
• W2620504089 hasConceptScore W2620504089C176944494 @default.
• W2620504089 hasConceptScore W2620504089C181199279 @default.
• W2620504089 hasConceptScore W2620504089C185592680 @default.
• W2620504089 hasConceptScore W2620504089C2776023528 @default.
• W2620504089 hasConceptScore W2620504089C2777844706 @default.
• W2620504089 hasConceptScore W2620504089C2779268695 @default.
• W2620504089 hasConceptScore W2620504089C2780258809 @default.
• W2620504089 hasConceptScore W2620504089C2781184954 @default.
• W2620504089 hasConceptScore W2620504089C2781259782 @default.
• W2620504089 hasConceptScore W2620504089C501734568 @default.
• W2620504089 hasConceptScore W2620504089C54355233 @default.
• W2620504089 hasConceptScore W2620504089C55493867 @default.
• W2620504089 hasConceptScore W2620504089C67705224 @default.
• W2620504089 hasConceptScore W2620504089C82381507 @default.
• W2620504089 hasConceptScore W2620504089C86803240 @default.
• W2620504089 hasIssue "7" @default.
• W2620504089 hasLocation W26205040891 @default.
• W2620504089 hasLocation W26205040892 @default.
• W2620504089 hasOpenAccess W2620504089 @default.
• W2620504089 hasPrimaryLocation W26205040891 @default.
• W2620504089 hasRelatedWork W1575261324 @default.
• W2620504089 hasRelatedWork W1793371687 @default.
• W2620504089 hasRelatedWork W1985653634 @default.

• next